HEPATIC FIBROSIS PREDICTS POOR RESPONSE TO PREOPERATIVE CHEMOTHERAPY, POSTOPERATIVE MALNUTRITION, AND POOR SURVIVAL IN PATIENTS WITH ESOPHAGEAL SQUAMOUS CELL CARCINOMA UNDERGOING MINIMALLY INVASIVE ESOPHAGECTOMY